Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06980766Completed

Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor

Role: collaborator

NCT06947447Completed

WatchPAT SpO2 Validation Study

Role: collaborator

NCT06682312Terminated

Philips Non-Invasive Blood Pressure Validation Study

Role: collaborator

NCT06535152Not ApplicableCompleted

Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study

Role: collaborator

All 4 trials loaded